Adiponectin circulating levels are decreased in the obese and insulin-resistant status, but are increased in normal weight individuals, thus representing a protective marker against obesity and type 2 diabetes [7]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.